SEC Form 4 · accession 0001178253-15-000068
SCYNEXIS INC · SCYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gonzalez David Angulo
Officer — Chief Medical Officer
Period of report
Jun 4, 2015
Accepted (ET)
Jun 5, 2015 · 5:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178253
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.65 | Jun 4, 2015 | A | 125,000 | A | — | Jun 3, 2025 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F125% of the shares subject to this option vests on the first anniversary of the grant date, and 6.25% of the shares subject to the option vest for each of the next 12 quarterly anniversaries thereafter, provided executive continues to provide continuous services to us.